Does Aptivus Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PROTEASE INHIBITORS/AMIODARONE
- SELECTED PROTEASE INHIBITORS/BEPRIDIL
- NIRMATRELVIR-RITONAVIR; TIPRANAVIR/FLECAINIDE; PROPAFENONE
- PROTEASE INHIBITORS/ORAL MIDAZOLAM; TRIAZOLAM
- SELECTED CYP3A4 INHIBITORS/PIMOZIDE
- PROTEASE INHIBITORS/ERGOT ALKALOIDS
- SELECTED CYP3A4 SUBSTRATES/RIFAMPIN
- SELECTED PROTEASE INHIBITORS/QUINIDINE
- PROTEASE INHIBITORS; COBICISTAT/ASTEMIZOLE; TERFENADINE
- SELECTED CYP3A4 SUBSTRATES/ST. JOHN'S WORT
- PROTEASE INHIBITORS/APALUTAMIDE
- STRONG CYP3A4 INHIBITORS/GEPIRONE
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/CISAPRIDE
- STR 3A4 INHIB;ATAZAN;DARUN/COLCHICINE (FOR CARDIOPROTECTION)
- STR CYP3A4 INHIBITORS; PROTEASE INHIB/PIMAVANSERIN (> 10 MG)
- STRONG CYP3A4 INHIBITORS/MAVACAMTEN
- TIPRANAVIR/ETRAVIRINE
- STRONG CYP3A4 INHIBITORS/PACRITINIB
- STRONG CYP3A4 INHIBITORS/DARIDOREXANT
- SELECTED STRONG CYP3A4 INHIBITORS/CONIVAPTAN
- STRONG CYP3A4 INHIBITORS/FINERENONE
- STRONG CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- TIPRANAVIR/TICAGRELOR
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (>10.5 MG)
- STRONG CYP3A4 INHIBITORS/UBROGEPANT
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR;DARUNAVIR/LERCANIDIPINE
- SLT STRONG & MODERATE CYP3A4 INHIBITORS/CILOSTAZOL (>50MG)
- STRONG CYP3A4 INHIBITORS/DAPAGLIFLOZIN-SAXAGLIPTIN-METFORMIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- ATAZANAVIR; TIPRANAVIR/GLECAPREVIR-PIBRENTASVIR
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (> 40 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- OATP1B1-3 INHIBITORS/ELBASVIR-GRAZOPREVIR
- SELECTED STRONG CYP3A4 INHIBITORS/ISAVUCONAZONIUM
- STRONG CYP3A4 INHIBITORS/PANOBINOSTAT (> 10 MG)
- STRONG CYP3A4 INHIBITORS/NALOXEGOL
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/AVANAFIL
- P-GP INDUCERS; PHENOBARBITAL/SELECTED HEPATITIS C AGENTS
- 3A4INHIB/DAPOXETINE;LEVOMILNACIPRAN(>80MG);VILAZODONE(>20MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- STRONG CYP3A4 INHIBITORS/SLT HIGH STRENGTH ANTIMUSCARINICS
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- TIPRANAVIR/ATORVASTATIN (>10 MG)
- PROTEASE INHIBITORS; COBICISTAT/LURASIDONE
- HIV PROTEASE INHIBITORS; COBICISTAT/SILDENAFIL (FOR PAH)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN (>2.5 MG)
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/DRONEDARONE
- HIV PROTEASE INHIBITORS; COBICISTAT/RIVAROXABAN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/RANOLAZINE
- STRONG CYP3A4 INHIBITORS/TOLVAPTAN
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/IVABRADINE
- PROTEASE INHIBITORS/ALFUZOSIN;SILODOSIN;TAMSULOSIN
- SELECTED PROTEASE INHIBITORS/VARDENAFIL (> 2.5 MG)
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/EPLERENONE
- STRONG CYP3A4 INHIBITORS/IRINOTECAN
- SELECTED PROTEASE INHIBITORS; COBICISTAT/ELETRIPTAN
- SELECTED CYP3A4 INHIBITORS/LOVASTATIN; SIMVASTATIN
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PROTEASE INHIBITORS/ALPRAZOLAM
- SELECTED PROTEASE INHIBITORS/RIFABUTIN; RIFAPENTINE
- PROTEASE INHIBITORS/CARBAMAZEPINE
- SELECTED PROTEASE INHIBITORS AND NNRTIS/GARLIC
- TIPRANAVIR/ANTICOAGULANTS; ANTIPLATELETS
- TIPRANAVIR/FLUCONAZOLE (>= 200 MG)
- PROTEASE INHIBITORS/ENZALUTAMIDE
- SELECTED SENSITIVE CYP3A4 SUBSTRATES/ADAGRASIB
- ANTI-RETROVIRALS/ATIDARSAGENE AUTOTEMCEL
- ANTI-RETROVIRALS/LOVOTIBEGLOGENE AUTOTEMCEL
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- STRONG CYP3A4 INHIBITORS/CAPIVASERTIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/REPOTRECTINIB
- STRONG CYP3A4 OR MODERATE CYP2C9 INHIBITORS/ERDAFITINIB
- STRONG CYP3A4 INHIBITORS/REBOXETINE
- SELECTED CYP3A4 INHIBITORS/MEPERIDINE
- STRONG CYP3A4 INHIBITORS/PALOVAROTENE
- STRONG CYP3A4 INHIBITORS/TRETINOIN
- STRONG CYP3A4 INHIBITORS/LENIOLISIB
- STRONG CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG CYP3A4 INHIBITORS/SPARSENTAN
- HIV PROTEASE INHIBITORS; COBICISTAT/APIXABAN
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- STRONG CYP3A4 INHIBITORS/PIRTOBRUTINIB
- SELECT PROTEASE INHIBITORS; COBICISTAT/TADALAFIL (BPH)
- DUAL STRONG CYP3A4 & P-GP INHIBITORS/FUTIBATINIB
- ANTI-RETROVIRALS/ELIVALDOGENE AUTOTEMCEL
- SELECTED STRONG CYP3A4 INHIBITORS/CLOZAPINE
- ANTI-RETROVIRALS; HYDROXYUREA/BETIBEGLOGENE AUTOTEMCEL
- PROTEASE INHIBITORS; COBICISTAT/TACROLIMUS
- SLT PROTEASE INHIBITORS;COBICISTAT/VONOPRAZAN-CLARITHROMYCIN
- STRONG CYP3A4 INHIBITORS/MITAPIVAT
- STRONG CYP3A4 INHIBITOR/TOLTERODINE (>1 MG IR OR >2 MG ER)
- STRONG CYP3A4 INHIBITORS/RIVOCERANIB
- STRONG CYP3A4 INHIBITORS/LEVOKETOCONAZOLE
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (>=30 MG)
- STRONG CYP3A4 INHIBITORS/RUPATADINE
- STRONG CYP3A4 INHIBITORS/SURUFATINIB
- STRONG CYP3A4 INHIBITORS/AVACOPAN
- STRONG CYP3A4 INHIBITORS/ATOGEPANT
- STRONG CYP3A4 INHIBITORS/MOBOCERTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/FEXINIDAZOLE
- MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
- OATP1B1-3 INHIBITORS/BRINCIDOFOVIR
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- STRONG CYP3A4 INHIBITORS/TOREMIFENE
- STRONG CYP3A4 INHIBITORS/SUNITINIB
- STRONG CYP3A4 INHIBITORS/PAZOPANIB
- STRONG CYP3A4 INHIBITORS/NILOTINIB
- STRONG CYP3A4 INHIBITORS/LAPATINIB
- STRONG CYP3A4 INHIBITORS/DASATINIB
- STRONG CYP3A4 INHIBITORS/CRIZOTINIB
- STRONG CYP3A4 INHIBITORS/CERITINIB
- STRONG CYP3A4 INHIBITORS/VINFLUNINE
- STRONG CYP3A4 INHIBITORS/VINCRISTINE
- STRONG CYP3A4 INHIBITORS/VINBLASTINE
- STRONG CYP3A4 INHIBITORS/TOFACITINIB
- STRONG CYP3A4 INHIBITORS/SONIDEGIB
- STRONG CYP3A4 INHIBITORS/RUXOLITINIB
- STRONG CYP3A4 INHIBITORS/PONATINIB
- STRONG CYP3A4 INHIBITORS/PALBOCICLIB
- STRONG CYP3A4 INHIBITORS/PACLITAXEL
- STRONG CYP3A4 INHIBITORS/OLAPARIB
- STRONG CYP3A4 INHIBITORS/IXABEPILONE
- STRONG CYP3A4 INHIBITORS/IDELALISIB
- STRONG CYP3A4 INHIBITORS/ERLOTINIB
- STRONG CYP3A4 INHIBITORS/DOXORUBICIN
- STRONG CYP3A4 INHIBITORS/DOCETAXEL
- STRONG CYP3A4 INHIBITORS/DABRAFENIB
- STRONG CYP3A4 INHIBITORS/COBIMETINIB
- STRONG CYP3A4 INHIBITORS/CABOZANTINIB
- STRONG CYP3A4 INHIBITORS/CABAZITAXEL
- STRONG CYP3A4 INHIBITORS/AXITINIB
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/SUVOREXANT
- DUAL STRONG CYP3A4 AND P-GP INHIBITORS/PRALSETINIB
- STRONG CYP3A4 INHIBITORS/PLITIDEPSIN
- DUAL CYP2D6 AND CYP3A4 INHIBITORS/ELIGLUSTAT
- STRONG CYP3A4 INHIBITORS/LURBINECTEDIN
- STRONG CYP3A4 INHIBITORS/SELPERCATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- STRONG CYP3A4 INHIBITORS/RIMEGEPANT
- STRONG CYP3A4 INHIBITORS/NIMODIPINE
- STRONG CYP3A4 INHIBITORS/TAZEMETOSTAT
- SELECTED CYP3A4 INHIBITORS/SALMETEROL COMBINATIONS
- STRONG CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- TIPRANAVIR/ATORVASTATIN (<=10 MG)
- STRONG CYP3A4 INHIBITORS/BOSUTINIB
- SELECTED PROTEASE INHIBITORS; COBICISTAT/CLOPIDOGREL
- PROTEASE INHIBITORS/QUETIAPINE
- STRONG CYP3A4 INHIBITORS/LAROTRECTINIB
- STRONG CYP3A4 INHIBITORS/GLASDEGIB
- STRONG CYP3A4 INHIBITORS/LORLATINIB
- STRONG CYP3A4 INHIBITORS/DUVELISIB
- STRONG CYP3A4 INHIBITORS/ELAGOLIX
- SELECTED STRONG CYP3A4 INHIBITORS/IVOSIDENIB
- STRONG CYP3A4 INHIBITORS/ARIPIPRAZOLE LAUROXIL SUBMICRONIZED
- STRONG AND MODERATE CYP3A4 INHIBITORS/ENCORAFENIB
- SELECTED STRONG CYP3A4 INHIBITOR;PROTEASE INHIB/DISOPYRAMIDE
- STRONG CYP3A4 INHIBITORS/RIBOCICLIB
- STRONG CYP3A4 INHIBITORS/VENETOCLAX
- STRONG CYP3A4 INHIBITORS/VEMURAFENIB
- OATP1B1 INHIBITORS/ELUXADOLINE
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/BEDAQUILINE;DELAMANID
- SLT STRONG CYP3A4 INHIBITOR & SUBSTRATE/LUMACAFTOR-IVACAFTOR
- STRONG CYP3A4 INHIBITORS/TRASTUZUMAB EMTANSINE
- STRONG 3A4 INHIBITORS/ESZOPICLONE > 2 MG; ZOPICLONE > 5 MG
- STRONG CYP3A4 INHIBITORS/DACLATASVIR
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/VORAPAXAR
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- STRONG CYP3A4 INHIBITORS/MACITENTAN
- DUAL STRONG CYP3A4 INHIBITOR & P-GP INHIBITORS/RIOCIGUAT
- SELECTED UGT1A & CYP3A4 INDUCERS/DOLUTEGRAVIR
- STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR/MIFEPRISTONE
- SELECTED PROTEASE INHIBITORS/QUININE
- SELECT CYP2C19 INHIBITORS/CITALOPRAM (>20 MG)
- COBICISTAT; PROTEASE INHIBITORS/SALMETEROL
- PROTEASE INHIBITORS/BOSENTAN
- STRONG CYP3A4 INHIBITORS; DARUNAVIR/EVEROLIMUS
- SLT PROTEASE INHIBITORS/BARBITURATES;PHENOBARBITAL;PHENYTOIN
- TIPRANAVIR/LOPINAVIR
- SELECTED PROTEASE INHIBITORS/MARAVIROC
- TIPRANAVIR/SAQUINAVIR MESYLATE
- PROTEASE INH;COBICISTAT/SLT IMMUNOSUPPRESSANTS;TEMSIROLIMUS
- STRONG CYP3A4 INHIBITORS/COLCHICINE
- SELECTED CYP3A4 INHIBITORS/SELECTED OPIOIDS
- TIPRANAVIR/AMPRENAVIR; FOSAMPRENAVIR
- SELECTED CYP3A4 INHIBITORS/TRAZODONE
- SELECTED CYP3A4 INHIBITORS/SELECTED STEROIDS
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PROTEASE INHIBITORS/NIRMATRELVIR-RITONAVIR
- STRONG CYP3A4 INHIBITORS/VAMOROLONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/ETRASIMOD
- OATP1B1-3 INHIBITORS/MOMELOTINIB
- SLT STRONG CYP3A4 INHIBIT/AMLODIPINE; LEVAMLODIPINE
- STRONG CYP3A4 INHIBITORS/ZURANOLONE
- STRONG CYP3A4 INHIBITORS/QUIZARTINIB
- STR CYP3A4 INHIB;ATAZAN;DARUNAV/SLT LONG-ACTING ARIPIPRAZOLE
- STRONG CYP3A4 INHIBITORS/BORTEZOMIB
- SELECT PROTEASE INHIBITORS; COBICISTAT/TADALAFIL (PAH)
- STRONG CYP3A4 INHIBITORS/VALBENAZINE (=< 40 MG)
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (<=10.5 MG)
- SELECTED CYP3A4 INHIBITORS/MOMETASONE
- STRONG CYP3A4 INHIBITORS/GILTERITINIB
- STRONG CYP3A4 INHIBITORS/TOLTERODINE (<=1 MG OR <=2 MG ER)
- STRONG CYP3A4 INHIBITORS/UPADACITINIB (<30 MG)
- STRONG CYP3A4 INHIBITORS/IBREXAFUNGERP
- STRONG CYP3A4 INHIBITORS/REPAGLINIDE
- PROTEASE INHIBITORS/SELECTED BENZODIAZEPINES
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- STRONG CYP3A4 INHIBITORS/FOSTAMATINIB
- STRONG CYP3A4 INHIBITORS/OSILODROSTAT
- SELECTED STRONG CYP3A4 INHIBITORS/ROMIDEPSIN
- STRONG CYP3A4 INHIBITORS/CANNABIDIOL-TETRAHYDROCANNABINOL
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/MEFLOQUINE
- SELECTED STRONG CYP3A4 INHIBITORS;PROTEASE INHIB/ILOPERIDONE
- COBICISTAT; TIPRANAVIR/MEXILETINE
- SELECTED PROTEASE INHIBITORS; COBICISTAT/LIDOCAINE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/BREXPIPRAZOLE
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (<= 15 MG)
- STRONG CYP3A4 INHIBITORS/MIDOSTAURIN
- STR CYP3A4 INHIBITORS;PROTEASE INHIB/PIMAVANSERIN (<= 10 MG)
- SELECTED CYP3A4 INHIBITORS/BROMOCRIPTINE; CABERGOLINE
- STRONG 3A4 INHIB/LEVOMILNACIPRAN(<=80MG);VILAZODONE(<=20MG)
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (> 15 MG)
- SELECTED MODERATE TO STRONG CYP2D6 INHIBITORS/TRAMADOL
- SELECTED CYP2C19 INHIBITORS/CITALOPRAM (<= 20 MG)
- STRONG CYP3A4 INHIBITORS/PANOBINOSTAT (<= 10 MG)
- SLT PROTEASE INHIB;COBICISTAT/SILDENAFIL (ED);TADALAFIL (ED)
- STRONG CYP3A4 INHIB;ATAZANAV;DARUNAVIR/SAXAGLIPTIN(<=2.5 MG)
- SLT STRONG CYP3A4 INHIBIT/SELECTED CALCIUM CHANNEL BLOCKERS
- STRONG CYP3A4 INHIBITORS/ESZOPICLONE; ZOPICLONE; ZOLPIDEM
- SELECTED CYP3A4 INHIBITORS/ITRACONAZOLE; KETOCONAZOLE
- STRONG CYP3A4 INHIBITORS/CINACALCET
- SELECTED PROTEASE INHIBITORS/VARDENAFIL (<= 2.5 MG)
- STRONG CYP3A4 INHIBITORS; ATAZANAVIR; DARUNAVIR/ARIPIPRAZOLE
- STRONG CYP3A4 INHIB; PROTEASE INHIB/ARTEMETHER;LUMEFANTRINE
- SELECTED PROTEASE INHIBITORS; COBICISTAT/CLARITHROMYCIN
- STRONG CYP3A4 INHIBITORS/SLT LOW STRENGTH ANTIMUSCARINICS
- SLT STRONG & MODERATE CYP3A4 INHIBITORS/CILOSTAZOL (<=50MG)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.